Workflow
Abaxx Exchange Reports Record Weekly Trading Volume
Globenewswire· 2026-03-23 11:00
Core Insights - Abaxx Technologies Inc. reported a record weekly trading volume of 54,740 contracts, marking a 343% increase from the previous week, with significant activity in gold and LNG markets [1][5] Trading Volume Highlights - The Abaxx Exchange achieved a new single-day volume record of 15,718 contracts on March 20, surpassing the previous record of 11,675 contracts set on March 18, 2026 [5] - Gold Singapore futures (GKS) reached a record weekly volume of 48,786 contracts, with a daily high of 13,390 contracts on March 20 [5] - Total trading volume for Q1 2026 reached 149,779 contracts, a 55% increase from 96,456 contracts in Q4 2025 [5] - Quarter-to-date volume for Gold Singapore futures increased by 60% to 102,939 contracts compared to 64,082 contracts in Q4 2025 [5] - LNG Futures volume increased by 18% to 37,886 contracts compared to 32,114 contracts in Q4 2025 [5] - Carbon futures volume increased significantly to 8,904 contracts from just 250 contracts in Q4 2025 [5] Market Development - The increase in trading volume reflects successful efforts to build initial liquidity in the markets, with ongoing expansion of connectivity across various trading participants [5][6] - The company anticipates that the initial liquidity will attract more participants, fostering further market development and maturation [6] Company Overview - Abaxx Technologies is focused on creating smarter markets through improved tools and technology, addressing challenges such as the energy transition [7] - The company operates the Abaxx Exchange and Abaxx Clearing, providing critical market infrastructure for a low-carbon economy [9] - Abaxx Spot modernizes physical gold trading with a physically-backed gold pool in Singapore, facilitating secure electronic transactions and efficient OTC transfers [10]
Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building 
Globenewswire· 2026-03-23 11:00
Core Viewpoint - Algernon Health Inc. is set to open its first brain PET scanning clinic in the U.S., targeting early detection of Alzheimer's Disease and other neurological conditions, with plans for multiple locations across the country [1][2]. Company Overview - Algernon Health Inc. is a Canadian healthcare company focused on brain-specific PET scanning services for early-stage detection of Alzheimer's Disease, dementia, epilepsy, neuro-oncology, and movement disorders like Parkinson's disease [16]. - The company has a subsidiary, Algernon NeuroScience, which is advancing a psychedelic program for stroke and traumatic brain injury recovery [16]. Clinic Details - The inaugural clinic will be located at the HCA Florida University Medical Office Building in Davie, Florida, with a five-year lease and an option for renewal [1]. - The clinic will utilize the CareMiBrain™ system, a standalone diagnostic PET scanner that reduces radiation exposure by 25% compared to traditional PET/CT scanners [3][13]. Market Opportunity - The clinic will be the first in the U.S. to provide brain-dedicated PET scans, which are covered by Medicare, Medicaid, and private insurance for patients aged 65 and older [2]. - There is a significant market opportunity for brain-specific PET scans due to the recent approval of monoclonal antibody treatments for Alzheimer's Disease, which require a positive beta-amyloid brain scan for patient authorization [4]. - The current supply of PET/CT scanners is insufficient to meet the growing demand for Alzheimer's diagnostics, as 45% of existing scanners are primarily used for cancer and cardiac imaging [5]. Business Strategy - The company plans to collaborate with local neurologists, geriatricians, and primary care physicians to generate patient referrals for brain PET scans [6]. - Direct marketing efforts will target the 50+ population to raise awareness about the benefits of early detection and management of Alzheimer's Disease [6]. - Recent findings indicate that nearly 80% of Americans would prefer to know if they have Alzheimer's Disease before symptoms appear, highlighting the demand for early diagnostic services [7]. Equipment and Technology - Algernon has signed a definitive equipment order with Catalyst MedTech for four CareMiBrain™ systems, valued at over CAD $4 million, with plans for additional systems for future clinics [8]. - The CareMiBrain™ system features advanced technology for high-quality imaging and patient comfort, including ergonomic design and fast acquisition times [15]. Location and Demographics - The flagship clinic in Davie, Florida, is strategically located within a 60-mile radius of over 6.4 million people, including 2.5 million aged 50 and over, providing access to a key target market for brain PET scan services [9].
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Globenewswire· 2026-03-23 11:00
Core Insights - Pyxis Oncology has completed target enrollment in the Phase 1 monotherapy dose expansion study of micvotabart pelidotin (MICVO) for 2L+ recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in Q1 2026, with updated data expected mid-2026 [1][5] - The company has appointed Thomas Civik as Interim Chief Executive Officer, focusing on clinical execution and operations to deliver robust datasets [3][6] - Financial results for the year ended December 31, 2025, show revenues of $13.9 million, a decrease from $16.1 million in 2024, with a net loss of $79.6 million [8][10] Clinical Development Updates - The Phase 1 monotherapy study of MICVO in 2L+ R/M HNSCC reported a 46% confirmed objective response rate (ORR) and a 92% disease control rate (DCR) [4] - In combination with KEYTRUDA, MICVO showed a 71% confirmed ORR and a 100% DCR in 1L/2L+ R/M HNSCC [4] - The ongoing studies are designed to evaluate the impact of modified weight-based dosing on safety and efficacy, with results anticipated in mid-2026 [7][11] Financial Performance - Total revenues for 2025 were $13.9 million, down from $16.1 million in 2024, primarily due to changes in milestone revenues and royalty rights [10][15] - Research and development expenses increased to $73.7 million in 2025 from $58.7 million in 2024, attributed to higher clinical trial costs [10][16] - The company reported a net loss of $79.6 million for 2025, slightly higher than the $77.3 million loss in 2024 [10][16] Leadership and Corporate Updates - Thomas Civik was appointed as Interim CEO in February 2026, bringing extensive experience in advancing cancer therapeutics [6][10] - Heather Knowles joined as Senior Vice President, Head of Global Clinical Operations, enhancing the company's clinical development capabilities [10] - The company has also appointed Alex Kane as Senior Vice President, Investor Relations and Capital Markets, to strengthen investor engagement [10] Pipeline and Future Outlook - Pyxis Oncology expects to report updated data from the ongoing MICVO Phase 1/2 combination study with KEYTRUDA in the second half of 2026 [7][11] - The company has received Fast Track Designation from the FDA for MICVO in treating adult patients with R/M HNSCC [12]
Vior Gold Corporation Announces Grants of Stock Options
Globenewswire· 2026-03-23 11:00
Core Viewpoint - Vior Gold Corporation has approved the grant of 4,825,000 stock options to its directors, officers, and key employees as part of its Omnibus Incentive Equity Plan [1][2]. Group 1: Stock Options Details - The granted stock options are subject to a three-year vesting period and have a seven-year term with an exercise price of $0.12 per common share [2]. - The options are governed by the terms of the Omnibus Plan, the applicable grant agreement, and the requirements of the TSX Venture Exchange [2]. Group 2: Company Overview - Vior Gold Corporation is a junior mineral exploration company based in Quebec, Canada, focusing on generating, exploring, and developing high-quality precious metals projects [3]. - The management and technical team of the corporation have a proven track record of discovering several multi-million ounces gold deposits in Quebec [3].
Landsbankinn hf.: S&P revises covered bond credit rating outlook from stable to positive
Globenewswire· 2026-03-23 10:58
Group 1 - S&P Global Ratings has revised the outlook on the credit rating of covered bonds issued by Landsbankinn from stable to positive [1] - Covered bonds issued by Landsbankinn are rated at A+ with a positive outlook [1] - This announcement follows a similar rating action by S&P on Iceland, where the long-term rating outlook was also revised from stable to positive [1]
Ashland implements pricing actions across product portfolio in response to market volatility
Globenewswire· 2026-03-23 10:55
Core Viewpoint - Ashland Inc. is implementing global pricing actions across its product portfolios in response to volatility in energy markets, raw material costs, and logistics conditions due to the conflict in the Middle East [1][2]. Group 1: Pricing Actions - The company is adjusting pricing to manage costs and maintain reliable supply to customers under current market conditions [2]. - Pricing actions will vary by product and region, reflecting local market dynamics, contractual terms, and individual customer requirements [2]. Group 2: Operational Adjustments - Ashland is taking proactive measures across procurement, supply chain, and operations to actively manage costs [2]. - The company will continue to monitor market conditions closely and adjust pricing and actions as market dynamics evolve [2]. Group 3: Company Overview - Ashland Inc. is a global additives and specialty ingredients company serving various consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care, and pharmaceuticals [3]. - The company employs approximately 2,900 individuals focused on developing innovative solutions for customers in over 100 countries [3].
Bowman Awarded $3.9 Million in New USGS Task Orders
Globenewswire· 2026-03-23 10:55
Core Insights - Bowman Consulting Group Ltd. has received new task orders totaling $3.9 million under the USGS Geospatial Products and Services Contract, focusing on multi-state airborne lidar data acquisition and elevation-derived hydrography products [1][2] Group 1: Financial and Contractual Developments - The new task orders enhance Bowman's federal backlog of high-value revenue and improve long-term visibility for manned-aerial revenue [2] - The work will be executed through Bowman's Merrick–Surdex Joint Venture, which has a decade-long relationship with USGS for aerial lidar data acquisition and processing [2] - The company anticipates additional opportunities as USGS advances national initiatives requiring high-quality topographic data, positioning the joint venture for sustained activity [2] Group 2: Company Overview - Bowman Consulting Group Ltd. is headquartered in Reston, Virginia, and employs over 2,500 staff across more than 100 locations in the U.S. [3] - The firm provides a range of services including planning, engineering, geospatial, construction management, and environmental consulting to various regulated end markets [3] - Bowman trades on the Nasdaq under the symbol BWMN [3]
AL Sydbank A/S share buyback programme: transactions in week 12
Globenewswire· 2026-03-23 10:51
Core Viewpoint - AL Sydbank A/S has initiated a share buyback programme amounting to DKK 1,100 million, aimed at reducing its share capital, which commenced on 2 March 2026 and is set to conclude by 31 January 2027 [1][2]. Group 1: Share Buyback Programme Details - The share buyback programme is executed in compliance with the Safe Harbour rules as per Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) 2016/1052 [2]. - As of week 12, a total of 66,000 shares were repurchased, with a gross value of DKK 33,910,240 [2]. - The accumulated total of shares repurchased during the programme stands at 205,000, with a gross value of DKK 107,869,360 [2]. Group 2: Transaction Breakdown - Specific transactions during week 12 include: - 13,000 shares on 16 March 2026 at a VWAP of 519.62, totaling DKK 6,755,060 [2]. - 10,000 shares on 17 March 2026 at a VWAP of 523.88, totaling DKK 5,238,800 [2]. - 10,000 shares on 18 March 2026 at a VWAP of 528.33, totaling DKK 5,283,300 [2]. - 10,000 shares on 19 March 2026 at a VWAP of 520.30, totaling DKK 5,203,000 [2]. - 23,000 shares on 20 March 2026 at a VWAP of 496.96, totaling DKK 11,430,080 [2]. Group 3: Current Holdings - Following the transactions, AL Sydbank A/S currently holds a total of 206,304 own shares, representing 0.23% of the Bank's share capital [4].
Onity Group Officially Rebrands PHH Mortgage to Onity Mortgage
Globenewswire· 2026-03-23 10:45
Core Insights - Onity Group Inc. has officially rebranded its mortgage subsidiary from PHH Mortgage Corporation to Onity Mortgage Corporation, marking a significant milestone in its multi-year transformation [1][2] Company Overview - Onity Group Inc. is a leading non-bank financial services company that provides mortgage servicing and origination solutions through Onity Mortgage Corporation. The company is one of the largest mortgage servicers in the United States, helping consumers and business clients achieve homeownership and financial goals [4] Brand Transformation - The rebranding to Onity Mortgage aims to unify the company's brand identity and reflects its current status as a technology-enabled mortgage company with strong growth momentum. The new name and tagline emphasize the company's commitment to action and customer success [2][3] - The rebranding includes the launch of redesigned websites and enhanced communication tools for clients and consumers, reinforcing the Onity brand across its customer base and the industry [2] Product Rebranding - The company's reverse mortgage product brand, Liberty Reverse Mortgage, has also been rebranded under the Onity Mortgage name, further consolidating the brand identity [3]
The 24th China International Alcoholic Drinks Expo Kicks Off in Luzhou, China's "City of Liquor"
Globenewswire· 2026-03-23 10:45
Core Insights - The 24th China International Alcoholic Drinks Expo was held from March 19 to 22, 2026, in Luzhou, Sichuan Province, with Thailand as the Guest Country of Honor [1][4] Industry Overview - The expo covered over 80,000 square meters, featuring exhibitors from nearly 50 countries and regions, with participation from over 1,000 enterprises and more than 10,000 products [4] - The exhibition included six major categories of alcoholic drinks: baijiu, beer, wine, huangjiu, fruit and liqueur-based spirits, and international distilled spirits [4] - A dedicated section for digital and intelligent innovation showcased the application of artificial intelligence in the liquor industry [4] Cultural Exchange - The Thailand Pavilion highlighted distinctive alcoholic products such as Chang beer, Singha beer, Thai whisky, and traditional rice wine, along with authentic Thai foods and cultural performances [4] - The event aimed to foster two-way exchange and win-win cooperation between Chinese and international liquor sectors [4] Economic Impact - The expo served as a platform for global dialogue, positioning Luzhou as an increasingly international place of origin for liquor [5] - It facilitated participation from nearly 50 enterprises and purchasers from renowned overseas producing regions, alongside more than 20 multilateral and bilateral trade and investment promotion events [5] Historical Significance - Luzhou is recognized for its exceptional baijiu craftsmanship, with traditional brewing techniques dating back over 700 years [6] - The event has evolved from the inaugural "Luzhou Famous Liquor Festival" in 1987 into a significant international expo, reflecting the industry's narrative of preservation and innovation [7]